18 main aim of these analyses was to determine whether any differences were present in laboratory tests, oral 19 health, or symptoms between AT and PTA patients. In addition, we examined whether different 20 subgroups of AT or PTA patients exist and whether laboratory values, bacterial findings, certain 21 symptoms, smoking, or oral health are related to a specific subgroup of patients. Table 1 . None of the patients developed a complication during the first 3 months. 10 11 Serum amylase and C-reactive protein levels 12 A significant inverse correlation was observed between S-Amyl (normal reference 28-100 U/l) and S-13 CRP (normal reference 0.05-3 mg/l) levels in both the AT and PTA groups (AT, r= -0.519, p≤0.001; 14 PTA, r= -0.353, p≤0.001; Fig 1) . We found no differences in the S-Amyl or S-CRP levels between the 15 AT and PTA groups (S-Amyl, p=0.767; S-CRP, p=0.501). Alcohol consumption and smoking habits had 16 no effect on S-Amyl levels (alcohol, p=0.750; smoking, p=0.205). No correlation was found between age 17 and CRP (AT and PTA patients r= -0.094, p=0.342; PTA patients r= -0.137, p=0.329). The S-Amyl and 18 S-CRP levels in AT and PTA patients are presented in Table 2. 19 20 Tonsillar findings 21 In patients with AT, the presence of tonsillar erythema, tonsillar exudate, or both had no effect on S-Amyl 22 (p=0.306) or S-CRP (p=0.363) levels. In the PTA group, eight patients did not have tonsillar erythema or 23 tonsillar exudate. These eight PTA patients had significantly lower S-CRP levels (median 15 mg/l, range 24 3-40 mg/l) than PTA patients presenting with tonsillar findings (median S-CRP 60 mg/l, range 3-313 25 mg/l; p<0.001). S-Amyl levels were slightly, but not significantly (p=0.190), higher in these eight patients 26 (median 49 U/l, range 27-82 U/l) compared to the other PTA patients (median 41 U/l, range 15-116 U/l; 27 Fig 2) . PTA patients without tonsillar findings were significantly older (median age 50.5 years, range 24-1 In patients treated with prior antibiotics, SAG was found more frequently than other bacteria (p=0.037).
2 Patients with SAG were significantly older (median age 45 years, range 27-53 years) than patients with 3 the following other bacteria: GAS (median age 30 years, range 20-58 years), non-SAG/beta-hemolytic 4 streptococci/FN (median age 31.5 years, range 18-65 years), or FN and FN+SAG (median age 25.5 years, 5 range 16-37 years; p=0.022). Seven out of nine patients (77.8%) with SAG were male. 6 7 DISCUSSION 8 Some of the PTA patients in this study had no tonsillar findings at clinical examination. In contrast, all 9 AT patients had tonsillar erythema, tonsillar exudate, or both. PTA patients presenting without tonsillar 10 erythema and tonsillar exudate had significantly lower S-CRP levels than PTA patients with tonsillar 11 findings. These eight patients without tonsillar findings were also older than other PTA patients. Thus, 12 patient characteristics, S-CRP, S-Amyl, and clinical findings may be tools for differentiating PTA patient 13 subgroups with different etiological factors [3, 5] . In addition, we found an inverse correlation between S-14 Amyl and S-CRP levels and lower S-CRP and higher S-Amyl levels in afebrile AT patients compared to 15 those with fever.
17 Strengths and limitations of the study
18 This prospective study is the first study to compare both S-CRP and S-Amyl between AT and PTA 19 patients, as well as between patients with different signs and symptoms of infection. One limitation of this 20 study is that only aerobic bacteria were analyzed in superficial throat bacterial cultures. In addition, 21 though both aerobes and anaerobes were tested in pus samples, some bacterial findings were so few that it 22 limited the statistical analysis. We did not exclude AT patients with earlier PTA (n=3) from the study, 23 which could have affected the results, but our cohort included very few of these patients. Patients with 24 alcohol abuse and pancreatic disease were excluded from the study, and none of the patients were 25 pregnant, but patients with other conditions causing elevated S-Amyl, such as gastrointestinal tract 26 infections, eating disorders, drug use, renal dysfunction, and macroamylasemia, were not excluded.
27 Furthermore, the evaluation of tonsillar findings (erythema, exudate) was based on subjective observation 1 by ear, nose, and throat physicians. However, due to prospective nature of the study, as well physicians' 2 substantial experience with tonsillar diseases, the evaluation can be considered reliable. Oral health was 3 also evaluated by an ear, nose, and throat physician, not a dentist, and classified only as good/poor. We 4 used the standard reference values to analyze S-Amyl and did not have the baseline S-Amyl value for the 5 112 patients. Therefore, it is impossible to determine the actual change in S-Amyl values caused by the 6 infection. Our material is consistent with previous studies concerning patient age, gender, oral health, and 7 smoking habits [2, 9, 19, 24] . We also observed that afebrile AT patients have lower S-CRP and higher S-Amyl levels than AT patients 7 with fever. One could speculate that salivary gland activation sometimes occurs in AT, though this 8 hypothesis has not been presented previously [4, 29] . AT patients with unilateral symptoms had lower S-9 CRP and higher S-Amyl levels than patients with bilateral throat pain, which could also indicate activity 10 in the minor salivary glands. We compared S-Amyl levels between PTA and AT patients and did not 11 observe a difference between the groups. El Saied et al. previously demonstrated a difference in both 12 serum and pus amylase levels between PTA patients and patients with deep neck abscesses and dental 13 abscesses [16, 17] . 14 15 In our study, GAS was the most prevalent bacterial finding in PTA patients, followed by SAG and FN. In 16 a recent Danish study of PTA, FN was the predominant pathogen, GAS was the second most common, 17 and group C Streptococcus was the third [22] . In this study, SAG was found in older patients and 18 predominately in males. Furthermore, SAG has been shown to predict the rapid recurrence of PTA and to 19 be found in older male patients [21, 30] . 20 21 Clinical applicability of the study 22 Our results suggest that the pathogenesis of PTA may differ between patients; thus, patient 23 characteristics, S-CRP and amylase levels, and clinical findings may be useful tools for differentiating 24 these PTA subgroups. For example, when differentiating between subgroups of PTA patients, we could 25 identify patients who would benefit from TE after the first PTA episode. Further studies are needed to 26 clarify the usability of these variables and their significance in helping choose the optimal treatment 27 strategy for different PTA patients. 3 The etiology of PTA is not as unambiguous as previously thought. Bacteria may not be the only factor 4 determining the course of the disease. There seems to be a subgroup of PTA patients without signs of 5 tonsillar infection that share features with parotitis. Therefore, it may be possible for PTA in these 6 patients to not begin as a complication of AT, but as an infection of the minor salivary glands. More 7 research is needed to examine the different subgroups of PTA and the role of minor salivary glands in 8 PTA and AT. 13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50 1 Haemophilus influenzae 2 (3.7) 1 (1.4) Neisseria meningitidis 0 (0) 1 (1.4) Staphylococcus aureus 0 (0) 3 (4.2) Other aerobic bacteria 0 (0) 0 (0) Anaerobic bacteria Fusobacterium necrophorum 5 (6.9) Other anaerobic bacteria b 22 (30.6) Mixed regional flora 28 (51.9) 13 (18.1) 1 2 AT, acute tonsillitis; PTA, peritonsillar abscess 3 a Only aerobic culture was performed for patients with acute tonsillitis (AT). 4 b Other anaerobic bacteria isolated: anaerobic Gram-negative rods (n=14), Prevotella species (n=2), 5 Fusobacterium species other than necrophorum (n=4), anaerobic mixed flora (n=2). 6 7 8 9 10 11 12 13 14 15
